Fig. 5
From: Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma
A–D The cellular viability test under the treatment of mocetinostat andclofarabine in human neuroblastoma cell lines SH-SY5Y and SH-N-AS. E Detection of cell apoptosis in cell line SH-SY-5Y under the treatment of mocetinostat and clofarabine by flow cytometry. F Statistical analysis of the sum of Q2 + Q4 for the cell early apoptosis and late apoptosis events under the treatment of mocetinostat and clofarabine. Unpaired t test was utilized to demonstrate statistical difference between DMSO control group and treatment groups. * P < 0.05, ** P < 0.01. G Detection of SMARCA4 protein expression level under the treatment of mocetinostat and clofarabine in cell line SH-N-AS by WB